Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02236130 · ClinicalTrials.gov registry record · NA
Peripheral Nerve Blocks in Pediatric Orthopedic Patients
A NA study, sponsored by University of Mississippi Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT02236130 is a NA study that was terminated before completion, run by University of Mississippi Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT02236130, a NA study, was terminated before completion, sponsored by University of Mississippi Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
Context: Single shot peripheral nerve blocks have limited duration of action depending on the local anesthetic agent used in the block. But it rarely lasts longer than 12 hrs. Patients need oral analgesics at home once the block wears off to control the pain. Objectives: Primary Objective To determine if peripheral nerve blocks have any advantage in terms of decreasing oral analgesic requirements in the post operative period even after the effects of the block have worn off Secondary Objective To determine if inclusion of single shot regional technique improves patient/family satisfaction with post operative pain management . Study Design: Prospective randomized single blinded study. Inclusion Criteria * Children aged between 6 yr and 17yr scheduled for ambulatory peripheral orthopedic surgery with moderate to severe postoperative pain. * Surgery of moderate duration (\<2hr) * Surgery associated with minimal blood loss or fluid shifts (\<10% total blood volume) * American Society of Anesthesiologists (ASA) classification 1 or 2 * Parents able to understand follow up instructions and are able to reach at home by phone Exclusion Criteria * Known allergy to local anesthetics * Preexisting neuropathy with sensory or motor deficits * Skin infection at site of needle placement * Parents refusal for peripheral nerve blocks
Interventions
- PROCEDURE General Anesthesia
- PROCEDURE Regional block
- DRUG Local Anesthetic Ropivacaine
- DRUG Opioids Morphine
- DRUG Oral pain medication Acetaminophen with Hydrocodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02236130
The ClinicalTrials.gov registry entry for NCT02236130 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which General Anesthesia is the first listed.
NCT02236130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02236130 about?
NCT02236130 is a clinical study titled "Peripheral Nerve Blocks in Pediatric Orthopedic Patients". Context: Single shot peripheral nerve blocks have limited duration of action depending on the local anesthetic agent used in the block. But it rarely lasts longer than 12 hrs. Patients need oral analgesics at home once the block wears off to control the pain. Objectives: Primary Objective To det...
What is the current status of trial NCT02236130?
This trial is currently terminated. It is a NA study. The enrollment target is 49 participants. The study started on 2014-06. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02236130?
The interventions under investigation include: General Anesthesia (PROCEDURE), Regional block (PROCEDURE), Local Anesthetic Ropivacaine (DRUG), Opioids Morphine (DRUG), Oral pain medication Acetaminophen with Hydrocodone (DRUG).
Who is sponsoring clinical trial NCT02236130?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.